V930 First in Man (FIM) Study (V930-002)(COMPLETED)

Clinical trial NCT00250419 · COMPLETED

Trial details

NCT number: NCT00250419
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancers Expressing HER-2 and/or CEA

Start date: 2005-09-01
Primary completion: 2008-09-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.